https://www.selleckchem.com/pr....oducts/wnt-c59-c59.h
9%) who read invitations enrolled in the study; 118 (94.4% of enrolled) completed MammoScreen. Twenty-one women were categorized as above-average risk from either MammoScreen data or the chart review and 7 (33.3%) were identified by both sources. Physicians and patients believed MammoScreen was easy to use and was helpful in identifying risks and facilitating shared decision-making. Conclusions Breast cancer risk assessment and mammography screening decision support were efficiently implemented through a web-based tool for patients